Oral squamous cell carcinomas: a histopathological review of multiple cases from Western Romania

Rom J Morphol Embryol. 2021 Oct-Dec;62(4):929-937. doi: 10.47162/RJME.62.4.05.

Abstract

Malignant tumors of the oral cavity have a growing incidence, most being squamous cell carcinomas, generally called oral cancers (OCs), clinically detected at various stages of natural evolution. The increased incidence in Romania in recent years and the lack of conclusive data have led to the development of this study. The main purpose of this study was to assess the molecular profile of tumors, the types of blood vessels associated with the tumor, and expression of tumor immunomarkers. Regarding morphological findings, focal epithelial hyperplasia, dysplastic lesions, typical mitoses, perineural invasion, parakeratosis and keratosis beads, intracytoplasmic keratinization were observed. Microvascular density was higher in the tumor area compared to the peritumoral area. Lymphovascular invasion was identified in 13% of cases, which also presented regional lymph node metastases. Podoplanin expression was identified in 79% of cases which were tested positive for the D2-40 immunomarker. All p53-positive cases co-expressed epidermal growth factor receptor (EGFR), half of the EGFR-positive cases co-expressed p53, and co-expression of CD117 and p63 was identified in 80% of EGFR-positive∕cytokeratin 5 (CK5)-positive cases being proposed the basal-like subtype of OCs, defined as EGFR-positive∕CK5-positive, CD117-positive and p63-positive. Results support the need for molecular classification of OCs based on of tumor immunomarker expression and gene analysis.

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • ErbB Receptors / genetics
  • Head and Neck Neoplasms*
  • Humans
  • Immunohistochemistry
  • Mouth Neoplasms* / pathology
  • Romania
  • Squamous Cell Carcinoma of Head and Neck
  • Tumor Suppressor Protein p53

Substances

  • Tumor Suppressor Protein p53
  • ErbB Receptors